The preventive treatment of migraine

被引:26
作者
Bigal, Marcelo E.
Lipton, Richard B.
机构
[1] Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10467 USA
[2] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA
[3] New England Ctr Headache, Stamford, CT USA
[4] Montefiore Headache Ctr, Bronx, NY USA
关键词
migraine prevention; preventive treatment;
D O I
10.1097/01.nrl.0000219666.65101.a9
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Migraine is a common, chronic, and disabling disorder. The treatment of migraine includes a combination of nonpharmacologic and pharmacologic techniques. Pharmacologic approaches are subdivided in preventive therapies and acute care. Review Summary: In this review article, we review the current approaches to the preventive treatment of migraine. Preventive treatment should be initiated in those with frequent or disabling headaches. The goals include (1) reducing attack frequency, intensity, and duration; (2) minimizing headache-related disability; (3) improving health-related quality of life; (4) avoiding headache escalation and medication misuse. In this article, we also discuss the principles of migraine prevention, as well as drugs available for this goal. We divide preventive medications on those of common use, nutraceutical compounds, and medications less frequently used. We close by briefly discussing some in-development potential preventive drugs. Conclusion: Preventive therapies are well suitable for migraineurs with attack-related disability despite appropriate acute care.
引用
收藏
页码:204 / 213
页数:10
相关论文
共 79 条
[1]
NIMODIPINE IN MIGRAINE PROPHYLAXIS [J].
ANSELL, E ;
FAZZONE, T ;
FESTENSTEIN, R ;
JOHNSON, ES ;
THAVAPALAN, M ;
WILKINSON, M ;
WOZNIAK, I .
CEPHALALGIA, 1988, 8 (04) :269-272
[2]
Bigal Marcelo E, 2004, Am J Ther, V11, P130, DOI 10.1097/00045391-200403000-00008
[3]
Botulinum toxin type A (BOTOX) for treatment of migraine headaches: An open-label study [J].
Binder, WJ ;
Brin, MF ;
Blitzer, A ;
Schoenrock, LD ;
Pogoda, JM .
OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2000, 123 (06) :669-676
[4]
Topiramate for migraine prevention - A randomized controlled trial [J].
Brandes, JL ;
Saper, JR ;
Diamond, M ;
Couch, JR ;
Lewis, DW ;
Schmitt, J ;
Neto, W ;
Schwabe, S ;
Jacobs, D .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (08) :965-973
[5]
MUSCLE MITOCHONDRIAL-DNA DELETION AND P-31-NMR SPECTROSCOPY ALTERATIONS IN A MIGRAINE PATIENT [J].
BRESOLIN, N ;
MARTINELLI, P ;
BARBIROLI, B ;
ZANIOL, P ;
AUSENDA, C ;
MONTAGNA, P ;
GALLANTI, A ;
COMI, GP ;
SCARLATO, G ;
LUGARESI, E .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1991, 104 (02) :182-189
[6]
AMITRIPTYLINE IN MIGRAINE PROPHYLAXIS [J].
COUCH, JR ;
HASSANEIN, RS .
ARCHIVES OF NEUROLOGY, 1979, 36 (11) :695-699
[7]
The orphanin FQ system: an emerging target for the management of pain? [J].
Darland, T ;
Grandy, DK .
BRITISH JOURNAL OF ANAESTHESIA, 1998, 81 (01) :29-37
[8]
Herbal medicines in migraine prevention [J].
DeWeerdt, CJ ;
Bootsma, HPR ;
Hendriks, H .
PHYTOMEDICINE, 1996, 3 (03) :225-230
[9]
Botulinum toxin type A for the prophylaxis of chronic daily headache: Subgroup analysis of patients not receiving other prophylactic medications: A randomized double-blind, placebo-controlled study [J].
Dodick, DW ;
Mauskop, A ;
Elkind, AH ;
DeGryse, R ;
Brin, MF ;
Silberstein, SD .
HEADACHE, 2005, 45 (04) :315-324
[10]
DRAKE ME, 2001, CEPHALALGIA, V21, P374